Abstract | BACKGROUND: MRP4/ABCC4 is an ATP-binding cassette transporter expressed in normal prostate. This study aimed to define the pattern of MRP4/ABCC4 expression in normal and malignant prostate tissue and the relationship of MRP4/ABCC4 expression and function in response to androgen signaling. METHODS: RESULTS: MRP4/ABCC4 mRNA/ protein levels were higher in localized PC compared to non- cancer (P = 0.006). MRP4/ABCC4 levels were significantly decreased in PCs treated with AA compared to cancers exposed to normal testosterone levels (P < 0.0001). MRP4/ABCC4 expression in normal human tissues was limited to the prostate and the renal tubules. MRP4/ABCC4 protein levels increased in LNCaP cells after DHT which was partially blocked by bicalutamide. However, DHT did not alter the activation of the MRP4/ABCC4 promotor in luciferase reporter assays and testosterone, DHT, flutamide and hydroxy- flutamide were not substrates for MRP4/ABCC4. DISCUSSION: Elevated MRP4/ABCC4 expression is found in malignant compared to benign prostate tissue while lower MRP4/ABCC4 expression is seen after AA. Furthermore, MRP4/ABCC4 is upregulated by androgen and downregulated by anti- androgen treatment in vitro potentially through an indirect mode of action. These data strongly suggest that MRP4/ABCC4 is an androgen-regulated gene important in the progression to PC and may be a potential drug target.
|
Authors | Lye Lin Ho, James G Kench, David J Handelsman, George L Scheffer, Phillip D Stricker, John G Grygiel, Robert L Sutherland, Susan M Henshall, John D Allen, Lisa G Horvath |
Journal | The Prostate
(Prostate)
Vol. 68
Issue 13
Pg. 1421-9
(Sep 15 2008)
ISSN: 1097-0045 [Electronic] United States |
PMID | 18615486
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | (c) 2008 Wiley-Liss, Inc. |
Chemical References |
- ABCC4 protein, human
- Androgen Antagonists
- Androgens
- Multidrug Resistance-Associated Proteins
- RNA, Messenger
- Dihydrotestosterone
- Testosterone
|
Topics |
- Adenocarcinoma
(metabolism, pathology)
- Aged
- Androgen Antagonists
(pharmacology)
- Androgens
(physiology)
- Case-Control Studies
- Cell Line, Tumor
- Cohort Studies
- Dihydrotestosterone
(pharmacology)
- Down-Regulation
(drug effects)
- Humans
- Male
- Middle Aged
- Multidrug Resistance-Associated Proteins
(metabolism)
- Prostatic Neoplasms
(metabolism, pathology)
- RNA, Messenger
(metabolism)
- Testosterone
(pharmacology)
- Up-Regulation
(drug effects)
|